Omneya Refaee, Oncology Medical Advisor at AstraZeneca, shared a post on LinkedIn:
“Grateful to have completed a 12-month Professional Program in Clinical Oncology Management, based on the American Board of Clinical Oncology Pharmacy curriculum, with an Excellent final assessment grade.
This program strengthened my scientific understanding of oncology pharmacotherapy, clinical trial data interpretation, and evidence-based treatment pathways, enabling more rigorous scientific exchange and data-driven support in my role as an Oncology Medical Advisor.”
More posts about Clinical Oncology.